Cancer Stem Cell & Oncology Research

Welcome Message

On behalf of the organizing committee, it is our immense pleasure to welcome you to the 17th International Conference on Cancer Stem Cell & Oncology Research, taking place on July 06-07, 2026, in Rome, Italy.

This conference serves as a premier gathering of global researchers, practitioners, and thought leaders in the fields of cancer stem cells and oncology. Over the next two days, we will explore groundbreaking advancements in cancer research, treatment innovations, and the emerging role of stem cells in cancer therapy.

We are excited to facilitate an environment that fosters collaboration, discussion, and innovation. The collective knowledge shared during this event will not only advance our understanding of cancer biology but will also pave the way for more effective treatments, improving the lives of patients worldwide.

Thank you for joining us in this important scientific journey. We look forward to a productive and inspiring conference.

Warm regards,
The Organizing Committee
17th International Conference on Cancer Stem Cell & Oncology Research

About Cancer Stem Cells 2026

The 17th International Conference on Cancer Stem Cell and Oncology Research (Cancer Stem Cells 2026) will be held on July 06–07, 2026, in Rome, Italy, bringing together global experts, researchers, clinicians, academicians, and industry professionals working in the rapidly evolving fields of cancer stem cell biology and oncology research. This international forum aims to foster scientific exchange, collaboration, and innovation focused on understanding cancer initiation, progression, resistance, and recurrence through stem cell–based mechanisms.

Cancer stem cells have emerged as a critical factor in tumor development, metastasis, and therapy resistance. This conference will highlight the latest discoveries in cancer stem cell signaling pathways, tumor heterogeneity, microenvironment interactions, and translational oncology approaches. Emphasis will be placed on bridging basic research with clinical applications to improve early diagnosis, personalized treatment strategies, and long-term patient outcomes.

Cancer Stem Cells 2026 will feature keynote lectures, plenary talks, oral presentations, and poster sessions delivered by leading international speakers. The scientific program will cover a wide range of topics including cancer stem cell biology, molecular oncology, targeted cancer therapies, immuno-oncology, drug resistance mechanisms, tumor biomarkers, regenerative oncology, and novel therapeutic technologies. Special focus will be given to emerging trends and innovative research shaping the future of cancer treatment.

The conference also serves as a valuable platform for early-career researchers, students, and clinicians to present their work, receive expert feedback, and build professional networks. Interactive discussions, networking sessions, and collaborative opportunities will encourage knowledge sharing and cross-disciplinary partnerships among academia, clinical practice, and industry.

Hosted in the historic city of Rome, the event combines high-level scientific discourse with an enriching cultural experience. Cancer Stem Cells 2026 aims to accelerate progress in oncology research by promoting multidisciplinary collaboration and advancing scientific understanding that translates into better cancer care worldwide.

Why to Attend Cancer Stem Cells 2026

Rome, the Eternal City, offers a perfect blend of history, culture, art, and modern lifestyle, making it an ideal destination for an international scientific conference.

Target Audience

• Cancer stem cell researchers and scientists
• Medical oncologists and radiation oncologists
• Clinical researchers and physician scientists
• Molecular biologists and cancer biologists
• Translational oncology researchers
• Immuno-oncology specialists
• Pathologists and diagnostic researchers
• Pharmaceutical and biotechnology professionals
• Drug discovery and development scientists
• Academic faculty and research scholars
• Postdoctoral fellows and graduate students
• Healthcare professionals involved in cancer care
• Biomedical and life science researchers
• Clinical trial coordinators and research associates
• Industry experts working on cancer therapeutics and diagnosticsa

Sessions & Tracks

Session 01: Biological Basis of Cancer Stem Cells

Cancer stem cells represent a distinct subpopulation of cells within malignant tumors that possess the biological ability to self renew and to generate diverse cell lineages found in cancer tissues. These cells share functional similarities with normal stem cells, including long term proliferative potential and differentiation capacity, but they differ in their dysregulated growth control and genomic instability. The biological origin of cancer stem cells remains an area of active investigation, with evidence suggesting that they may arise either from transformed normal stem cells or from differentiated cancer cells that reacquire stem like features through genetic and epigenetic alterations. At the cellular level, cancer stem cells exhibit slow cycling behavior, resistance to cellular stress, and enhanced survival mechanisms, allowing them to persist within tumors over extended periods. They play a central role in maintaining tumor architecture by continuously replenishing the bulk population of cancer cells. Molecularly, cancer stem cells are characterized by the expression of stemness associated genes that regulate self renewal, pluripotency, and cellular fate decisions. These biological properties contribute to tumor initiation, growth sustainability, and cellular hierarchy. Understanding the biological foundation of cancer stem cells is essential for explaining why tumors behave as dynamic and evolving systems rather than uniform masses of identical cells.

Session 02: Tumor Cellular Heterogeneity and Stem Cell Hierarchy

Tumors are biologically heterogeneous systems composed of multiple cell populations with distinct genetic, epigenetic, and phenotypic characteristics. Cancer stem cells play a fundamental role in generating and maintaining this heterogeneity through hierarchical organization. Within this hierarchy, cancer stem cells occupy the apex and give rise to progenitor like cancer cells, which further differentiate into more specialized tumor cell types. This process mirrors normal tissue development but occurs in a deregulated and unstable manner. Cellular heterogeneity is driven by accumulated mutations, chromosomal instability, and epigenetic variability, all of which are amplified by the self renewing nature of cancer stem cells. Environmental pressures such as hypoxia, nutrient limitation, and inflammatory signals further influence cell fate decisions, contributing to spatial and temporal diversity within tumors. Importantly, cancer stem cells exhibit plasticity, allowing non stem cancer cells to regain stem like features under specific biological conditions. This reversible state transition increases tumor adaptability and complexity. From a biological perspective, tumor heterogeneity complicates the understanding of cancer progression because different cell populations may exhibit distinct growth patterns and survival advantages. Studying the hierarchical and plastic nature of tumor cell populations provides critical insight into how cancers evolve, adapt, and persist over time.

Session 03: Self Renewal and Differentiation Mechanisms

Self renewal is a defining biological property of cancer stem cells that enables them to produce identical daughter cells while maintaining the stem cell pool. This process is tightly regulated by intracellular transcriptional networks and extracellular signals that control cell division symmetry. In symmetric division, two identical stem cells are produced, expanding the stem cell population, whereas asymmetric division results in one stem cell and one differentiated progeny. Differentiation involves the progressive restriction of cellular potential, leading to specialized tumor cell types that form the bulk of the tumor mass. These biological processes are governed by coordinated gene expression programs that regulate cell fate decisions. Dysregulation of self renewal mechanisms leads to uncontrolled proliferation and tumor expansion. Cancer stem cells exploit normal developmental pathways to sustain continuous growth while avoiding terminal differentiation. Importantly, differentiation in cancer does not restore normal tissue function but instead generates malignant cells with altered morphology and behavior. The balance between self renewal and differentiation is dynamic and influenced by microenvironmental cues, genetic mutations, and epigenetic modifications. Understanding these biological mechanisms provides a framework for explaining tumor maintenance and long term persistence at the cellular level.

Session 04: Epigenetic Regulation in Cancer Stem Cells

Epigenetic regulation plays a central biological role in maintaining cancer stem cell identity without altering the underlying DNA sequence. Epigenetic mechanisms include DNA methylation, histone modification, and chromatin remodeling, all of which influence gene expression patterns. In cancer stem cells, epigenetic plasticity allows rapid adaptation to environmental changes and cellular stress. Genes associated with stemness are often epigenetically activated, while differentiation related genes are suppressed. This reversible regulation enables cancer stem cells to transition between stem like and non stem states. Aberrant epigenetic landscapes contribute to cellular instability and promote malignant behavior. Unlike genetic mutations, epigenetic changes are dynamic and responsive to external signals, making them powerful drivers of tumor evolution. These biological processes also influence lineage commitment, cellular memory, and long term survival. Studying epigenetic regulation in cancer stem cells enhances understanding of how cellular identity is maintained and altered during cancer progression.

Session 05: Metabolic Characteristics of Cancer Stem Cells

Cancer stem cells exhibit distinct metabolic characteristics that support their long term survival and self renewal capacity. Unlike differentiated tumor cells that often rely on a single dominant metabolic pathway, cancer stem cells display metabolic flexibility, allowing them to adapt to fluctuating nutrient and oxygen availability. They can shift between glycolytic metabolism and mitochondrial oxidative processes depending on environmental conditions. This adaptability supports energy production, redox balance, and biosynthetic demands. Metabolic regulation is closely linked to stemness signaling and cellular fate decisions. Altered lipid metabolism and amino acid utilization also contribute to membrane synthesis and stress resistance. Reactive oxygen species levels are tightly controlled in cancer stem cells, preventing oxidative damage while maintaining signaling functions. These metabolic traits distinguish cancer stem cells from other tumor cell populations and highlight the biological integration of metabolism with cellular identity. Understanding these metabolic features provides insight into how cancer stem cells maintain viability in hostile tumor environments.

Session 06: Genetic Instability and Cancer Stem Cells

Genetic instability is a fundamental biological characteristic of cancer stem cells and plays a critical role in tumor initiation and evolution. Unlike normal stem cells, which maintain strict genomic integrity to preserve tissue function, cancer stem cells accumulate mutations, chromosomal rearrangements, and copy number variations over time. These alterations arise from defective DNA repair mechanisms, replication stress, and exposure to oxidative damage within the tumor environment. Despite this instability, cancer stem cells retain the ability to self renew, suggesting the presence of selective mechanisms that allow survival of advantageous genetic variants. Genetic diversity generated within cancer stem cell populations fuels clonal evolution, enabling tumors to adapt to changing biological conditions. This instability contributes to functional heterogeneity, where different cancer stem cell clones exhibit distinct growth rates, differentiation patterns, and survival capacities. Importantly, genetic instability does not occur randomly but is shaped by selective pressures such as hypoxia, nutrient limitation, and cellular competition. The accumulation of mutations affecting cell cycle regulation, apoptosis control, and differentiation pathways further enhances malignant behavior. Understanding genetic instability in cancer stem cells provides insight into how tumors continuously evolve and why cancer progression is often unpredictable and dynamic at the biological level.

Session 07: Stemness Gene Networks in Cancer

Stemness in cancer stem cells is maintained through complex gene regulatory networks that control self renewal, pluripotency, and cell fate decisions. These networks involve transcription factors that regulate large sets of genes associated with undifferentiated cellular states. In cancer stem cells, these regulatory circuits become deregulated, leading to sustained expression of stem cell associated genes and suppression of differentiation programs. This altered gene expression landscape allows cancer stem cells to maintain their identity over extended periods. Interactions between transcription factors and epigenetic modifiers stabilize stemness states while allowing flexibility in response to environmental cues. These gene networks do not function in isolation but are influenced by intracellular signaling pathways and extracellular signals from the surrounding tumor environment. Subtle changes in gene expression can shift the balance between self renewal and differentiation, contributing to cellular plasticity. From a biological perspective, stemness gene networks represent the molecular foundation of cancer stem cell behavior and are essential for maintaining tumor organization and long term growth.

Session 08: Cellular Plasticity in Cancer Stem Cells

Cellular plasticity refers to the ability of cancer cells to transition between different phenotypic states, including stem like and differentiated states. Cancer stem cells exhibit high levels of plasticity, enabling them to adapt to fluctuating biological conditions within tumors. This flexibility allows differentiated cancer cells to reacquire stem cell properties under specific environmental or molecular influences. Plasticity is regulated by transcriptional reprogramming, epigenetic modifications, and metabolic shifts. Through this dynamic process, cancer stem cells contribute to tumor resilience and complexity. Plasticity also allows cancer stem cells to occupy diverse functional roles, including proliferation, migration, and dormancy. The reversible nature of these state transitions challenges traditional hierarchical models of tumor organization. Instead, tumors are better understood as dynamic systems where cellular identity is fluid rather than fixed. Studying plasticity enhances understanding of how cancer stem cells maintain population stability while enabling rapid adaptation to biological stress.

Session 09: Hypoxia and Cancer Stem Cell Biology

Low oxygen conditions are a defining feature of the tumor microenvironment and have profound biological effects on cancer stem cells. Hypoxia promotes the maintenance of stem like properties by activating oxygen sensitive transcriptional programs that support self renewal and inhibit differentiation. Cancer stem cells are particularly well adapted to survive under reduced oxygen availability due to metabolic flexibility and enhanced stress response mechanisms. Hypoxic conditions influence gene expression patterns associated with stemness, survival, and cellular quiescence. These environmental cues contribute to the formation of specialized niches where cancer stem cells preferentially reside. Hypoxia also promotes genomic instability and epigenetic remodeling, further enhancing cellular diversity. By shaping cancer stem cell behavior, oxygen availability becomes a critical regulator of tumor architecture and evolution. Understanding hypoxia related biological mechanisms provides insight into how environmental factors influence cancer stem cell maintenance.

Session 10: Quiescence and Dormancy in Cancer Stem Cells

Quiescence is a reversible non proliferative state that allows cancer stem cells to survive unfavorable biological conditions. Unlike actively dividing tumor cells, quiescent cancer stem cells remain metabolically active but do not undergo cell division. This state protects them from cellular stress and preserves long term self renewal capacity. Quiescence is regulated by cell cycle control mechanisms, metabolic adaptation, and transcriptional repression of proliferation associated genes. Dormant cancer stem cells can persist for extended periods within tumors, contributing to long term disease maintenance. Environmental signals such as nutrient availability and cellular crowding influence entry into and exit from quiescence. From a biological standpoint, quiescence represents a survival strategy that allows cancer stem cells to balance growth with preservation. Studying this state enhances understanding of tumor persistence and cellular longevity.

Session 11: Cell Cycle Regulation in Cancer Stem Cells

Cell cycle regulation in cancer stem cells is fundamentally altered compared to normal somatic cells, enabling sustained self renewal and long term survival. These cells possess the ability to precisely control transitions between active proliferation and growth arrest, allowing them to respond dynamically to internal and external biological cues. Key regulatory checkpoints that normally prevent uncontrolled cell division are frequently deregulated, resulting in abnormal progression through cell cycle phases. Despite this deregulation, cancer stem cells retain selective control over proliferation to avoid exhaustion of the stem cell pool. This balance is achieved through coordinated regulation of cyclins, cyclin dependent kinases, and checkpoint proteins that govern entry into DNA synthesis and mitosis. Cancer stem cells often exhibit prolonged cell cycle phases or reversible arrest, contributing to population stability. Disruption of normal cell cycle timing increases the likelihood of replication errors and mutation accumulation, further driving genetic diversity. Importantly, cell cycle control is tightly linked to differentiation decisions, as exit from the cell cycle often precedes lineage commitment. In cancer stem cells, this link is weakened, allowing continuous propagation of undifferentiated states. Understanding cell cycle regulation at the biological level provides insight into how cancer stem cells maintain proliferative potential while preserving stemness characteristics.

Session 12: DNA Damage Response Mechanisms

Cancer stem cells exhibit unique DNA damage response mechanisms that enable survival despite high levels of genomic stress. DNA damage arises from replication errors, oxidative stress, and chromosomal instability within the tumor environment. In response, cancer stem cells activate complex signaling networks that detect DNA lesions and coordinate repair processes. These mechanisms include enhanced recognition of DNA breaks and efficient activation of repair pathways. Unlike differentiated tumor cells, cancer stem cells prioritize genome maintenance to preserve long term self renewal capacity. However, repair processes in these cells are often error prone, leading to the accumulation of mutations rather than complete restoration of genomic integrity. This paradox allows survival while promoting genetic variability. DNA damage response pathways also interact with cell cycle regulation, determining whether cells proceed with division or enter temporary arrest. Persistent activation of these responses contributes to cellular adaptation and evolution. From a biological perspective, altered DNA damage responses in cancer stem cells represent a balance between protection and mutation generation, enabling both survival and diversification within tumors.

Session 13: Chromatin Organization and Cellular Identity

Chromatin organization plays a central role in maintaining cancer stem cell identity by controlling access to genetic information. The spatial arrangement of DNA and associated proteins determines which genes are active or silenced. In cancer stem cells, chromatin exists in a flexible and dynamic state that supports rapid changes in gene expression. Regions associated with stemness remain accessible, while differentiation related regions are compacted and repressed. This organization allows cancer stem cells to preserve an undifferentiated state while retaining the ability to respond to environmental signals. Chromatin remodeling complexes actively modify nucleosome positioning, enabling transitions between cellular states. Disruption of normal chromatin architecture contributes to transcriptional instability and abnormal gene regulation. These changes reinforce stem like properties and support cellular plasticity. Chromatin based regulation also integrates metabolic signals and stress responses, linking cellular physiology to gene expression control. Studying chromatin organization provides essential biological insight into how cancer stem cells maintain identity and adaptability.

Session 14: Cellular Polarity and Asymmetric Division

Cellular polarity is a fundamental biological feature that influences how cancer stem cells divide and distribute cellular components. Polarity establishes spatial differences within the cell, guiding the orientation of the mitotic spindle and determining the fate of daughter cells. During asymmetric division, polarity ensures that one daughter cell retains stem cell characteristics while the other undergoes differentiation. In cancer stem cells, polarity mechanisms are frequently disrupted, leading to altered division patterns. This disruption may result in excessive self renewal or abnormal differentiation. Despite these abnormalities, cancer stem cells often retain partial polarity, allowing flexible control over division outcomes. The distribution of signaling molecules, transcription factors, and organelles during division contributes to fate determination. Altered polarity enhances tumor expansion by favoring stem cell maintenance. Understanding the biological role of polarity in cancer stem cells helps explain how tumors sustain long term growth and cellular diversity.

Session 15: Intercellular Communication Within Tumors

Intercellular communication is essential for coordinating cancer stem cell behavior within complex tumor ecosystems. Cancer stem cells exchange signals with neighboring cancer cells, stromal cells, and immune related cells through direct contact and secreted factors. These signals regulate self renewal, differentiation, and survival. Communication networks create localized microenvironments that support stem like properties. Feedback mechanisms allow cancer stem cells to sense population density and environmental conditions, adjusting behavior accordingly. Disruption of normal tissue communication pathways contributes to loss of growth control and malignant progression. Signaling gradients influence spatial organization of stem cell populations within tumors. From a biological perspective, intercellular communication integrates individual cell behavior into coordinated tumor dynamics, reinforcing the central role of cancer stem cells in tumor organization.

Session 16: Role of the Tumor Microenvironment

The tumor microenvironment plays a decisive biological role in regulating the behavior and maintenance of cancer stem cells. It consists of surrounding cellular and non cellular components that influence stem cell identity through constant interaction. Cancer stem cells do not exist in isolation but are embedded within specialized niches that provide physical support and biochemical signals. These niches regulate self renewal, differentiation, and survival by modulating gene expression and cellular metabolism. Environmental factors such as oxygen availability, nutrient gradients, mechanical forces, and extracellular matrix composition shape cancer stem cell behavior. Cellular components within the microenvironment release signaling molecules that reinforce stem like properties and suppress differentiation. This bidirectional communication allows cancer stem cells to remodel their surroundings, creating conditions that favor long term persistence. The microenvironment also contributes to cellular plasticity by enabling transitions between stem like and non stem states. Spatial organization within tumors results in regional differences in stem cell density and activity. From a biological perspective, the tumor microenvironment acts as a regulatory system that stabilizes cancer stem cell populations and integrates environmental cues into cellular decision making.

Session 17: Inflammation Driven Regulation of Cancer Stem Cells

Inflammatory signaling represents a significant biological influence on cancer stem cell behavior and identity. Chronic inflammation alters tissue homeostasis and creates conditions that favor malignant transformation and stemness maintenance. Inflammatory mediators produced within tumors activate transcriptional programs that promote self renewal and inhibit differentiation. Cancer stem cells respond to these signals by adjusting gene expression patterns associated with survival and proliferation. Persistent inflammatory environments increase genetic instability and epigenetic variability, enhancing cellular diversity. Inflammation also reshapes the tumor microenvironment, reinforcing niche conditions that support stem like populations. Crosstalk between inflammatory signaling and stemness pathways amplifies malignant traits. From a biological standpoint, inflammation acts as a driver of cancer stem cell expansion and functional adaptation. Studying this relationship provides insight into how systemic biological processes influence cellular identity within tumors.

Session 18: Migration and Invasive Properties of Cancer Stem Cells

Cancer stem cells possess distinct biological features that enable migration and invasion within tissue environments. These cells can alter adhesion properties, cytoskeletal organization, and extracellular matrix interactions to facilitate movement. Migration is regulated by coordinated changes in gene expression and cellular polarity. Cancer stem cells exhibit enhanced responsiveness to environmental gradients, allowing directional movement through complex tissue structures. Invasive behavior is closely linked to cellular plasticity, enabling transitions between stationary and migratory states. These properties contribute to spatial redistribution of stem cell populations within tumors. Migration also exposes cancer stem cells to diverse microenvironments, promoting further adaptation. From a biological perspective, migratory capacity enhances tumor complexity and structural organization. Understanding these processes reveals how cancer stem cells actively shape tumor architecture.

Session 19: Cellular Stress Response in Cancer Stem Cells

Cancer stem cells are exposed to continuous biological stress arising from metabolic imbalance, hypoxia, and genomic instability. To survive, they activate adaptive stress response mechanisms that preserve cellular integrity. These responses include modulation of protein folding, metabolic regulation, and redox balance. Cancer stem cells maintain controlled levels of reactive oxygen species to prevent damage while supporting signaling functions. Stress response pathways also influence cell cycle control and quiescence. Persistent activation of these mechanisms enables long term survival under adverse conditions. However, adaptive responses also increase tolerance to instability, allowing accumulation of mutations. From a biological standpoint, stress adaptation represents a survival strategy that supports stem cell persistence and tumor evolution.

Session 20: Evolutionary Dynamics of Cancer Stem Cell Populations

Cancer stem cell populations evolve continuously through biological selection and adaptation. Genetic variation, epigenetic flexibility, and environmental pressure drive population level changes over time. Cells with advantageous traits preferentially survive and expand, reshaping tumor composition. Evolutionary dynamics are influenced by niche availability, resource competition, and cellular interactions. Cancer stem cells act as reservoirs of diversity, generating progeny with varied characteristics. This ongoing evolution results in dynamic tumor systems rather than static structures. Cellular plasticity accelerates adaptation by enabling rapid phenotype switching. From a biological perspective, cancer progression reflects an evolutionary process governed by selection, variation, and inheritance within stem cell populations. Understanding these dynamics provides a comprehensive framework for interpreting tumor behavior at the cellular level.

Global Cancer Stem Cells Market Analysis

The global cancer stem cells market has shown consistent growth over the past few years and is expected to expand significantly over the next five years, driven by the increasing global cancer burden and rising focus on targeted and personalized oncology therapies. In 2024, the market was valued at approximately USD 3.1 billion, supported by growing research activities in cancer biology, stem cell signaling pathways, and tumor resistance mechanisms. Continuous investments from pharmaceutical companies, biotechnology firms, and academic research institutions have strengthened the development of cancer stem cell–based diagnostic and therapeutic approaches.

By 2026, the market is estimated to reach around USD 3.6 to 3.8 billion, reflecting strong growth in translational research and clinical trials targeting cancer stem cells. Advancements in cell isolation technologies, molecular profiling, and single-cell analysis have accelerated research productivity and therapeutic innovation. Increased funding for oncology research, along with the rising adoption of precision medicine, continues to drive demand for cancer stem cell-focused solutions across both research and clinical settings.

Looking ahead to 2029–2030, the global cancer stem cells market is projected to grow to approximately USD 5.5 to 6.0 billion, registering a compound annual growth rate of nearly 10 to 12 percent over the five-year period. North America currently holds the largest market share due to strong research infrastructure and high healthcare spending, while the Asia Pacific region is expected to witness the fastest growth owing to expanding healthcare systems, increasing cancer incidence, and growing investment in biomedical research.

Overall, the market outlook for cancer stem cells remains highly positive, with long-term growth supported by continuous innovation in oncology therapeutics, increasing collaboration between academia and industry, and a strong emphasis on overcoming cancer recurrence and treatment resistance. These trends highlight the growing clinical and commercial importance of cancer stem cell research, positioning it as a key driver in the future of global oncology advancements.

Global Associations and Societies

• American Association for Cancer Research
• European Society for Medical Oncology
• International Society for Stem Cell Research
• American Society of Clinical Oncology
• National Cancer Institute
• Cancer Research United Kingdom
• Society for Immunotherapy of Cancer
• European Society of Oncology Pharmacy
• World Health Organization – International Agency for Research on Cancer
• International Society for Cell and Gene Therapy

Participants & Participation Options

Speaker

• Deliver keynote or invited lectures at the conference.
• Share cutting-edge research, innovations, and scientific insights with global delegates.

Delegate/ Listener

• Attend scientific sessions, panel discussions, and networking events.
• Access conference materials and interact with experts across the field of cancer stem cell and oncology research.

Poster Presenter

• Showcase original research through printed or digital posters.
• Engage in one-on-one discussions with attendees and subject experts.

Exhibitor

• Display products, technologies, or services in dedicated exhibition spaces.
• Network with delegates, potential clients, and research collaborators.

Video Presentation

• Present research findings or innovations through recorded video sessions.
• Ideal for participants who are unable to attend the conference in person.

E-Poster Presenter

• Share research electronically through interactive e-posters.
• Participate in virtual discussions and question-and-answer sessions with attendees.

Virtual Registration

• Attend live-streamed keynote sessions, scientific presentations, and panel discussions online.
• Access conference recordings, digital materials, and participate in virtual networking activities.
• Ideal for international participants or those unable to attend in person.

Participant Benefits

• Earn continuing professional development or continuing medical education points

• Networking opportunities with global experts and peers

• Certificate of participation

• Digital object identifier publication opportunities in conference proceedings

• Access to cutting-edge cancer stem cell and oncology research

• Enhanced professional visibility for speakers, presenters, and exhibitors

• Opportunities for global research collaboration

Abstract Submission & Registration Timeline

• Abstract Submission Open: Now Open
• Early Bird Registration: February 06, 2026
• Standard Registration: April 06, 2026
• Final Registration Deadline: July 06, 2026

Abstract Submission Details

• All abstracts will undergo a peer-review process to ensure scientific quality and relevance.
• Authors will receive an abstract acceptance letter upon approval, confirming inclusion in the scientific program.
• Accepted abstracts will be published in the conference proceedings with a digital object identifier, providing global visibility and citation opportunities.

For Inquiries

For any questions or assistance regarding the 17th International Conference on Cancer Stem Cell and Oncology Research, abstract submission, registration, or participation, please contact:

• Email: contact@speakermeeting.com
• Phone: +44 2880 090005
• Website: https://cancerstemcells.insightconferences.com/

Past Conference Report

Cancer Stem Cells 2025

Join us at the 16th International Conference on Cancer Stem Cell & Oncology Research (Cancer Stem Cells 2025), taking place on November 24-25,2025, in the vibrant city of Bercelona,Spain. This conference will focus on the theme "Precision Medicine Approaches for Cancer Stem Cell Targeting," bringing together leading experts, researchers, and practitioners in the field of oncology and cancer stem cell research.

As cancer continues to challenge medical science, innovative approaches are essential for improving patient outcomes. This conference aims to delve into cutting-edge research and advancements in precision medicine that target cancer stem cells, which play a critical role in tumorigenesis and therapy resistance.

Participants will have the opportunity to engage in thought-provoking discussions, attend keynote presentations from renowned speakers, and network with peers to foster collaboration. We encourage submissions of abstracts highlighting novel findings and methodologies related to cancer stem cells and precision oncology.

Join us in shaping the future of cancer treatment and research at Cancer Stem Cells 2025—where science meets innovation for a healthier tomorrow.